New research presented at this year’s European Congress of Clinical Microbiology & Infectious Diseases (ECCMID) in Amsterdam, Netherlands (13-16 April)
Continue reading »Home » Health Problems »
Discovering hallucinogenic mushrooms in Mexico
Before being qualified as “magic” and becoming the global phenomenon they are today, certain mushrooms were considered as sacred by
Continue reading »Fathers are vitally important to their kids’ health and to public health research
Helping our children to develop healthy eating, exercise and screen-time behaviours is an important public health goal globally. This is
Continue reading »Research finds new Rx target for childhood cancer
Research led by Michael Lan, Ph.D., Professor of Pediatrics and Genetics at LSU Health New Orleans School of Medicine, found
Continue reading »Child vaccination levels falling short in large parts of Africa
A study by the University of Southampton shows that several low-and middle-income countries, especially in Africa, need more effective child
Continue reading »Web-based parent training intervention for childhood disruptive behaviour successful in primary health care
Transferring an evidence-based treatment to practice is not self-evident but requires extensive work. The study published in the open access
Continue reading »Many cancer patients take alternative meds but don’t tell their doctors
(HealthDay)—One out of every three U.S. cancer patients uses alternative or complementary therapies, but many keep that info from their
Continue reading »Cancer sufferers’ hair loss misery during chemo could be over
Scientists at the University of Huddersfield aim to minimise, or eliminate completely, the hair loss that is one of the
Continue reading »The protein p38-gamma identified as a new therapeutic target in liver cancer
An enzyme involved in cell stress responses could become a new pharmacological target in the treatment of liver cancer, a
Continue reading »A new molecule to improve treatment for type 2 diabetes and non-alcoholic fatty liver disease
A new molecule, EPB-53, could help fight type 2 diabetes and non-alcoholic fatty liver disease, according to a new study
Continue reading »